💊image loading
(from DailyMed)

nitrofurantoin macrocrystals 100 mg Capsule, 100-count — NDC 70756-412-11 (Billing 70756-0412-11)

by Lifestar Pharma LLC · 100 CAPSULE in 1 BOTTLE

This is a package of 100 capsules of nitrofurantoin macrocrystals 100 mg Capsule from Lifestar Pharma LLC, marketed since Mar 2023 and currently FDA-listed; retail pharmacies pay about $0.2327 per capsule (NADAC). It is this product's only package size.

NDC 70756-0412-11
🏷️ FDA NDC (as labeled) 70756-412-11 billing pads the product segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 70756-412-11 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
70756 labeler · 412 product · 11 package
Package marketed since
Mar 21, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 7075641211 3
Medicaid fills, this package
43,759 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70756-412-11
Product NDC 70756-412
11-digit billing NDC 70756041211
NCPDP billing unit EA — each (per item)
Application # ANDA217272
SPL Set ID 1d837605-3632-4da1-8c6e-b51cabcec18b
Established class (EPC) Nitrofuran Antibacterial
Chemical class Nitrofurans
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-03-21
Route ORAL
Dosage form CAPSULE
Substance NITROFURANTOIN
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 009428
GCN 41820
HICL code 004087
Ingredient (HICL) Nitrofurantoin Macrocrystal
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W2
Therapeutic class — intermediate (HIC2) Antibacterials
HIC3 code W2F
Therapeutic class — specific (HIC3) Nitrofuran Derivatives Antibacterial Agents
AHFS code 08:36.00.00
AHFS class Urinary Anti-Infectives
FDB label name NITROFURANTOIN MCR 100 MG CAP
FDB brand name Nitrofurantoin
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 009428
  • GCN: 41820
  • HICL (First Databank): 004087
  • AHFS class code: 08:36.00.00
Why two NDCs? The FDA registers this code as 70756-412-11 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 70756-0412-11. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name NITROFURANTOIN MCR 100 MG CAP Ingredient Nitrofurantoin Macrocrystal
📖 What it is MedlinePlus · NLM

Nitrofurantoin is used to treat urinary tract infections. Nitrofurantoin is in a class of medications called antibiotics. It works by killing bacteria that cause infection. Antibiotics such as nitrofurantoin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Nitrofurantoin is an antibiotic specifically for urinary tract infections — think bladder infections, not kidney infections. It works by concentrating in your urine where it kills...
  • What exactly is nitrofurantoin used for?
  • Yes, every time. Taking nitrofurantoin with food isn't just about avoiding an upset stomach — food actually helps your body absorb more of the medication, so it works better. Even...
  • Do I really need to take it with food every single time?
📖 Read our full Nitrofurantoin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.233 $23.27 / 100 capsules
Medicaid paysCMS SDUD · 12 mo $0.7290 $72.90 / 100 capsules
Medicare drug plans payPart D · Q2 2026 $0.3581 $35.81 / 100 capsules
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 Jan 2026 May 2026 Sep 2026 $0.423 $0.221
▼ Down 44% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70756-0412-11 You're viewing this Main listing 100 CAPSULE in 1 BOTTLE 2023-03-21 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Nitrofurantoin Macrocrystals 100 mg 00115-1645-01 Amneal 100 capsules $0.233 AB Availability likely —
Nitrofurantoin Macrocrystals 100 mg 50268-0624-15 AvPAK 50 capsules $0.233 AB Availability likely —
nitrofurantoin (macrocrystals) 100 mg 59651-0795-01 Aurobindo 100 capsules $0.233 AB Availability likely —
Nitrofurantoin Macrocrystals 100 mg 60687-0850-01 American 100 capsules $0.233 AB Availability likely —
Nitrofurantoin 100 mg 62332-0391-31 Alembic 100 capsules $0.233 AB Availability likely —
nitrofurantoin macrocrystals 100 mg 68001-0605-00 BluePoint 100 capsules $0.233 AB Availability likely —
nitrofurantoin macrocrystals 100 mgthis 70756-0412-11 Lifestar 100 capsules $0.233 AB Availability likely —
nitrofurantoin macrocrystals 100 mg 72603-0184-01 NorthStar 100 capsules $0.233 AB Availability likely —
Nitrofurantoin macrocrystals 100 mg 43386-0642-01 Lupin 100 capsules $0.242 AB Availability likely +4%
nitrofurantoin macrocrystals 100 mg 47781-0308-01 Alvogen 100 capsules $0.395 — Discontinued +70%
Nitrofurantion 100 mg 68001-0386-00 BluePoint 100 capsules $0.395 — FDA listed +70%
nitrofurantoin macrocrystals 100 mg 68382-0560-01 Zydus 100 capsules $0.437 AB FDA listed +88%
Nitrofurantoin 100 mg 46708-0391-31 Alembic 100 capsules — AB FDA listed —
Nitrofurantion 100 mg 50090-5693-00 A-S 28 capsules — — FDA listed —
nitrofurantoin 100 mg 50090-7217-00 A-S 28 capsules — AB FDA listed —
nitrofurantoin (macrocrystals) 100 mg 50090-7308-00 A-S 28 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 51655-0948-20 Northwind 20 capsules — — FDA listed —
Macrodantin 100 mg 52427-0288-01 Almatica 100 capsules — — Discontinued —
Nitrofurantion 100 mg 57664-0233-18 Sun 1000 capsules — — FDA listed —
Nitrofurantoin Macrocrystals 100 mg 61919-0842-14 Direct_Rx 14 capsules — AB FDA listed —
Nitrofurantion Macrocrystals 100 mg 63187-0245-10 Proficient 10 capsules — — FDA listed —
Nitrofurantoin Macrocrystals 100 mg 67296-2150-01 Redpharm 10 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 67296-2251-04 Redpharm 14 capsules — AB FDA listed —
Nitrofurantion 100 mg 68071-2363-07 NuCare 14 capsules — — FDA listed —
nitrofurantoin macrocrystals 100 mg 70518-3827-00 REMEDYREPACK 14 capsules — AB FDA listed —
Nitrofurantoin 100 mg 70518-4244-00 REMEDYREPACK 30 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 70771-1171-00 Zydus 1000 capsules — AB FDA listed —
Nitrofurantion 100 mg 71205-0171-10 Proficient 10 capsules — — FDA listed —
Nitrofurantoin Macrocrystals 100 mg 71205-0297-10 Proficient 10 capsules — AB FDA listed —
Nitrofurantion 100 mg 71335-0024-01 Bryant 40 capsules — — FDA listed —
nitrofurantoin 100 mg 71335-1069-01 Bryant 40 capsules — AB FDA listed —
Nitrofurantoin 100 mg 71335-1135-01 Bryant 40 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 71335-2212-01 Bryant 40 capsules — AB FDA listed —
Nitrofurantoin Macrocrystals 100 mg 72789-0270-02 PD-Rx 2 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 72789-0340-10 PD-Rx 10 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 82804-0131-14 Proficient 14 capsules — AB FDA listed —
Nitrofurantoin 100 mg 82804-0241-14 Proficient 14 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 82868-0015-14 Northwind 14 capsules — AB FDA listed —
nitrofurantoin macrocrystals 100 mg 83939-0016-01 VERITYRX, 1 capsule — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Mar 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Nitrofurantoin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerLifestar Pharma LLC
Application holderMANKIND PHARMA LTD
FDA applicationANDA217272 (ANDA)
Labeler code70756
First marketedMar 2023
Product typeHuman Prescription Drug
Portfolio157 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
43.8K
Units reimbursed last 4 qtrs
773.5K
Gross reimbursed last 4 qtrs
$563.9K
Avg / prescription
$12.89
Avg / unit
$0.7290
Latest quarter Q1 2026
10KRx
Medicaid pays / ea
$0.7290
gross reimbursed
vs
NADAC / ea
$0.2327
acquisition cost
=
Spread
+$0.4963
+213% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
35% FFS 65% MCO
Fee-for-service · 15,123 Rx Managed care · 28,636 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 5,241 units · 67.1 per 100k residents WA Idaho: 890 units · 45.3 per 100k residents ID Montana: 1,235 units · 109 per 100k residents MT North Dakota: no data reported ND Minnesota: 1,431 units · 24.9 per 100k residents MN Wisconsin: 3,768 units · 63.8 per 100k residents WI Michigan: 14,426 units · 144 per 100k residents MI New York: 54,701 units · 280 per 100k residents NY Vermont: no data reported VT New Hampshire: 1,363 units · 97.2 per 100k residents NH Oregon: 4,039 units · 95.4 per 100k residents OR Nevada: 14,683 units · 460 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 3,233 units · 101 per 100k residents IA Illinois: 14,606 units · 116 per 100k residents IL Indiana: 24,616 units · 359 per 100k residents IN Ohio: 23,324 units · 198 per 100k residents OH Pennsylvania: 28,670 units · 221 per 100k residents PA New Jersey: 15,797 units · 170 per 100k residents NJ Massachusetts: 21,485 units · 307 per 100k residents MA California: 118,034 units · 303 per 100k residents CA Utah: 2,268 units · 66.4 per 100k residents UT Colorado: 5,079 units · 86.4 per 100k residents CO Nebraska: 1,973 units · 99.7 per 100k residents NE Missouri: 13,160 units · 212 per 100k residents MO Kentucky: 13,938 units · 308 per 100k residents KY West Virginia: 8,663 units · 489 per 100k residents WV Virginia: 23,378 units · 268 per 100k residents VA Maryland: 28,864 units · 467 per 100k residents MD Connecticut: 9,647 units · 267 per 100k residents CT Rhode Island: 5,383 units · 492 per 100k residents RI Arizona: 21,483 units · 289 per 100k residents AZ New Mexico: 6,730 units · 318 per 100k residents NM Kansas: 1,635 units · 55.6 per 100k residents KS Arkansas: 5,086 units · 166 per 100k residents AR Tennessee: 13,137 units · 184 per 100k residents TN North Carolina: 28,727 units · 265 per 100k residents NC South Carolina: 12,236 units · 228 per 100k residents SC Delaware: 1,814 units · 176 per 100k residents DE Oklahoma: 9,784 units · 241 per 100k residents OK Louisiana: 23,956 units · 524 per 100k residents LA Mississippi: 5,736 units · 195 per 100k residents MS Alabama: 13,565 units · 266 per 100k residents AL Georgia: 18,387 units · 167 per 100k residents GA D.C.: 3,098 units · 456 per 100k residents DC Hawaii: 3,235 units · 225 per 100k residents HI Texas: 46,091 units · 151 per 100k residents TX Florida: 53,751 units · 238 per 100k residents FL
Units reimbursed · per 100k residents
24.9524
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Louisiana 524 /100k
2 Rhode Island 492 /100k
3 West Virginia 489 /100k
4 Maryland 467 /100k
5 Nevada 460 /100k
6 D.C. 456 /100k
7 Indiana 359 /100k
8 New Mexico 318 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.